Bold Therapeutics Inc.
$65,000.00 CAD
≈ 10 months of average Canadian pay
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2025-2026
- Agreement period
- January 1, 2026 – July 13, 2026
- Reference
- nrc-cnrc:172-2025-2026-Q4-1038281
Published purpose
This project will investigate the mode of action of neuroprotective activity of BOLD-100, the Firm's lead metallotherapeutic candidate for cancer therapy.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported July 30, 2026 from open.canada.ca Grants & Contributions